Hybrid cardiac rehabilitation trial (HYCARET): protocol of a randomised, multicentre, non-inferiority trial in South America

被引:9
|
作者
Seron, Pamela [1 ]
Oliveros, Maria J. [1 ]
Marzuca-Nassr, Gabriel N. [2 ]
Lanas, Fernando [1 ]
Morales, Gladys [3 ]
Roman, Claudia [4 ]
Munoz, Sergio R. [5 ]
Saavedra, Nicolas [6 ]
Grace, Sherry L. [7 ,8 ]
机构
[1] Univ La Frontera, CIGES, Internal Med Dept, Temuco, Chile
[2] Univ La Frontera, Internal Med Dept, Temuco, Chile
[3] Univ La Frontera, EPICYN, Publ Hlth Dept, Temuco, Chile
[4] Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile
[5] Univ La Frontera, CIGES, Publ Heath Dept, Temuco, Chile
[6] Univ La Frontera, Basic Sci Dept, Temuco, Chile
[7] York Univ, Fac Hlth, Toronto, ON, Canada
[8] Univ Toronto, Univ Hlth Network, KITE & Peter Munk Cardiac Ctr, Toronto, ON, Canada
来源
BMJ OPEN | 2019年 / 9卷 / 10期
关键词
MYOCARDIAL-INFARCTION; PERFORMANCE-MEASURES; PHYSICAL-ACTIVITY; DELIVERY MODEL; PREVENTION; STATEMENT; ASSOCIATION; RECOMMENDATIONS; QUESTIONNAIRE; COUNCIL;
D O I
10.1136/bmjopen-2019-031213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Cardiac rehabilitation (CR) programmes are well established, and their effectiveness and cost-effectiveness are proven. In spite of this, CR remains underused, especially in lower-resource settings such as Latin America. There is an urgent need to create more accessible CR delivery models to reach all patients in need. This trial aims to evaluate if the prevention of recurrent cardiovascular events is not inferior in a hybrid CR programme compared with a standard programme. Method and analysis A non-inferiority, pragmatic, multicentre, parallel (1:1), prospective, randomised and open with blinded endpoint assessment clinical trial will be conducted. 308 patients with coronary artery disease will be recruited consecutively. Participants will be randomised to hybrid or standard rehabilitation programme. The hybrid CR programme includes 10 supervised exercise sessions and individualised lifestyle counselling by a physiotherapist, with a transition after 4-6 weeks to unsupervised delivery via text messages and phone calls. The standard CR consists of 18-22 supervised exercise sessions, as well as group education sessions about lifestyle. Intervention in both groups is between 8 and 12 weeks. The primary outcome is a composite of cardiovascular mortality and hospitalisations due to cardiovascular causes. Secondary outcomes are health-related quality of life, exercise capacity, muscle strength, heart-healthy behaviour, return-to-work, cardiovascular risk factor, adherence, and exercise-related adverse events. The outcomes will be measured at the end of intervention, at 6 months and at 12 months follow-up from recruitment. The primary outcome will be tracked through the end of the trial. Per-protocol and intention-to-treat analysis will be undertaken. Cox regression model will be used to compare primary outcome among study groups. Ethics and dissemination Ethics committees at the sponsor institution and each centre where participants will be recruited approved the study protocol and the Informed Consent. Research findings will be published in peer-reviewed journals; additionally, results will be disseminated among region stakeholders.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Comparison of a structured home-based rehabilitation programme with conventional supervised pulmonary rehabilitation: a randomised non-inferiority trial
    Horton, Elizabeth J.
    Mitchell, Katy E.
    Johnson-Warrington, Vicki
    Apps, Lindsay D.
    Sewell, Louise
    Morgan, Mike
    Taylor, Rod S.
    Singh, Sally J.
    THORAX, 2018, 73 (01) : 29 - 36
  • [32] Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial
    Trutnovsky, Gerda
    Reich, Olaf
    Joura, Elmar A.
    Holter, Magdalena
    Ciresa-Koenig, Alexandra
    Widschwendter, Andreas
    Schauer, Christian
    Bogner, Gerhard
    Jan, Ziga
    Boandl, Angelika
    Kalteis, Martin S.
    Regauer, Sigrid
    Tamussino, Karl
    LANCET, 2022, 399 (10337): : 1790 - 1798
  • [33] Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial
    Arnold, Donald M.
    Heddle, Nancy M.
    Cook, Richard J.
    Hsia, Cyrus
    Blostein, Mark
    Jamula, Erin
    Sholzberg, Michelle
    Lin, Yulia
    Kassis, Jeannine
    Larratt, Loree
    Tinmouth, Alan
    Amini, Sufia
    Schipperus, Martin
    Lim, Wendy
    Vishnu, Prakash
    Warner, Margaret
    Carruthers, Julie
    Li, Na
    Lane, Shannon
    Kelton, John G.
    LANCET HAEMATOLOGY, 2020, 7 (09): : E640 - E648
  • [34] EXtending Omalizumab Treatment Intervals in patients with Chronic spontaneous urticaria (EXOTIC): protocol of a multicentre, randomised, open-label, non-inferiority trial
    Zhang, Ditte Georgina
    Sorensen, Jennifer Astrup
    Ghazanfar, Misbah Noshela
    Ali, Zarqa
    Vestergaard, Christian
    Thyssen, Jacob
    Egeberg, Alexander
    Thomsen, Simon Francis
    BMJ OPEN, 2025, 15 (01):
  • [35] MinT-trial: Mindfulness versus cognitive behavioural therapy in Tinnitus patients: protocol for a randomised controlled, non-inferiority trial
    Rademaker, Maaike Maartje
    Stegeman, Inge
    Lieftink, Arno
    Somers, Metten
    Stokroos, Robert
    Smit, Adriana L.
    BMJ OPEN, 2020, 10 (02):
  • [36] OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial
    Sheppard, James P.
    Burt, Jenni
    Lown, Mark
    Temple, Eleanor
    Benson, John
    Ford, Gary A.
    Heneghan, Carl
    Hobbs, F. D. Richard
    Jowett, Sue
    Little, Paul
    Mant, Jonathan
    Mollison, Jill
    Nickless, Alecia
    Ogburn, Emma
    Payne, Rupert
    Williams, Marney
    Yu, Ly-Mee
    McManus, Richard J.
    BMJ OPEN, 2018, 8 (09):
  • [37] Electroacupuncture versus solifenacin succinate for female overactive bladder: study protocol for a multicentre, randomised, controlled, double-dummy, non-inferiority trial
    Chen, Bingli
    Yin, Ping
    Li, Juanjuan
    Hou, Wenguang
    Fan, Qian
    Huai, Yisheng
    Liu, Lumin
    Hu, Junwei
    Chow, Sandra Teresa
    Li, Xu
    Ming, Shuren
    Chen, Yue-Lai
    BMJ OPEN, 2024, 14 (09):
  • [38] Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial
    Javaud, Nicolas
    Soria, Angele
    Maignan, Maxime
    Martin, Ludovic
    Descamps, Vincent
    Fain, Olivier
    Bouillet, Laurence
    Berard, Frederic
    Tazarourte, Karim
    Roy, Pierre-Marie
    Fontaine, Jean-Paul
    Bagot, Martine
    Khellaf, Mehdi
    Goulet, Helene
    Lapostolle, Frederic
    Casalino, Enrique
    Doutre, Marie-Sylvie
    Gil-Jardine, Cedric
    Caux, Frederic
    Chosidow, Olivier
    Pateron, Dominique
    Vicaut, Eric
    Adnet, Frederic
    BMJ OPEN, 2019, 9 (08):
  • [39] Effect of reactive balance training on physical fitness poststroke: study protocol for a randomised non-inferiority trial
    Barzideh, Azadeh
    Marzolini, Susan
    Danells, Cynthia
    Jagroop, David
    Huntley, Andrew H.
    Inness, Elizabeth L.
    Mathur, Sunita
    Mochizuki, George
    Oh, Paul
    Mansfield, Avril
    BMJ OPEN, 2020, 10 (06): : e035740
  • [40] Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis: the protocol of a multicentre, non-inferiority, double-blinded and randomised controlled trial
    Solheim, Anne Marit
    Ljostad, Unn
    Mygland, Ase
    BMJ OPEN, 2019, 9 (06):